ライフサイエンスコーパス: murine leukemia virus

1 oduction and also enhanced the production of murine leukemia virus.

2 than to those of oncoretroviral RTs, such as murine leukemia virus.

3 loaded onto unintegrated DNAs of the Moloney murine leukemia virus.

4 or with the amphotropic envelope protein of murine leukemia virus.

5 (HIV-1), simian immunodeficiency virus, and murine leukemia virus.

6 rted infection of one cell line (DEL) with a murine leukemia virus.

7 of the RNAs packaged by a model retrovirus, murine leukemia virus.

8 dimerization and packaging domain of Moloney murine leukemia virus.

9 ived growth factor (PDGF)-containing Moloney murine leukemia viruses.

10 ion of proviral integration site for Moloney murine leukemia virus 1 kinase (PIM-1).

11 PIM1 (Proviral Integration site for Moloney murine leukemia virus 1) has emerged as a key regulator

12 kinase proviral integration site for Moloney murine leukemia virus-1 (PIM-1), which in turn regulates

13 The Abelson murine leukemia virus (A-MuLV) expresses an alternative

14 Abelson murine leukemia virus (Ab-MLV) arose from a recombinatio

15 Transformation by Abelson murine leukemia virus (Ab-MLV) is a multistep process in

16 l protein tyrosine kinase encoded by Abelson murine leukemia virus (Ab-MLV) transforms pre-B cells.

17 ginal pipeline, can identify integrations of murine leukemia virus, adeno-associated virus, Tol2 tran

18 rupted restriction activity against N-tropic murine leukemia virus and equine infectious anemia virus

19 Based on previous studies of murine leukemia virus and HIV-1, we hypothesized that un

20 , similar to canonical retroviruses, such as murine leukemia virus and HIV.

21 provide a high-resolution atlas of m(5)C in murine leukemia virus and reveal a functional role of m(

22 fective HIV-1 or Vpu(-) retroviruses such as murine leukemia virus and simian immunodeficiency virus.

23 uently than simple gammaretroviruses such as murine leukemia virus and spleen necrosis virus.

24 on site pattern of XMRV with those found for murine leukemia virus and two human retroviruses, human

25 gene delivery by wild-type ecotropic Moloney murine leukemia virus and vesicular stomatitis virus (VS

26 some glycoproteins, such as those encoded by murine leukemia virus and vesicular stomatitis virus, we

27 OBEC3F (A3F), which are potent inhibitors of murine leukemia virus and Vif-deficient human immunodefi

28 ene whose overexpression blocks infection by murine leukemia viruses and human immunodeficiency virus

29 stigate to what extent virions of HERV-Kcon, murine leukemia virus, and HIV-1 have the ability to tra

30 ents derived from three retroviruses (HIV-1, murine leukemia virus, and Mason-Pfizer monkey virus), t

31 ell lines blocked cytokine induction by HIV, murine leukemia virus, and simian immunodeficiency virus

32 The integration pattern of murine leukemia virus appears to be largely driven by re

33 een XMRV and the intensively studied Moloney murine leukemia virus, architectures of the regulatory d

34 tiviruses and distinct from those of Moloney murine leukemia virus, avian sarcoma leukosis virus, and

35 mbined immunodeficiency (SCID-X1), a Moloney murine leukemia virus-based gamma-retrovirus vector expr

36 sduction efficiency by both HIV- and Moloney murine leukemia virus-based retroviral vectors.

37 By employing a murine leukemia virus-based single-cycle infection assay

38 r more than 1 year after transduction with a murine leukemia virus-based vector encoding the T-cell g

39 We have observed a novel phenotype in a murine leukemia virus capsid mutant, which has normal vi

40 us, MoFe2, or with the parent virus, Moloney murine leukemia virus, caused significant reduction in B

41 The retrovirus ts1, a mutant of Moloney murine leukemia virus, causes oxidative stress and progr

42 so suggest that the leader region of Moloney murine leukemia virus contains inhibitory/regulatory seq

43 ollowed by reverse transcription via Moloney murine leukemia virus, degradation of chromosomal DNA wi

44 of sequences in the 3' U3 region of Moloney murine leukemia virus-derived retroviral vectors.

45 se APOBEC3 does not catalyze base changes in murine leukemia virus DNA, it can be recovered from thes

46 are rapidly loaded onto unintegrated Moloney murine leukemia virus DNAs.

47 ed multiple clonal integrations of ecotropic murine leukemia virus (E-MuLV).

48 Murine leukemia viruses encode a unique form of Gag poly

49 rt of this hypothesis, infection of HIV-1 or murine leukemia virus Env (MLV-Env)-pseudotyped HIV-1 pa

50 lays a defect in proteolytic cleavage of the murine leukemia virus Env cytoplasmic tail in pseudotype

51 d with HIV-1, vesicular stomatitis virus, or murine leukemia virus Env glycoproteins.

52 The trimeric Moloney murine leukemia virus Env protein matures by two proteol

53 urface (SU) or transmembrane (TM) protein of murine leukemia virus Env, along with point mutations th

54 The membrane-proximal region of murine leukemia virus envelope (Env) is a critical modul

55 native viral glycoproteins, including Friend murine leukemia virus envelope (F-MLV Env) are actively

56 For murine leukemia virus envelope (MLV Env) glycoprotein, i

57 For murine leukemia virus envelope (MLV Env) glycoprotein, i

58 or-binding sequence of the ecotropic Moloney murine leukemia virus envelope glycoprotein with the pep

59 studied how the protomeric units of Moloney murine leukemia virus envelope protein (Env) are activat

60 udotyped with vesicular stomatitis virus and murine leukemia virus envelopes, indicating that defensi

61 support viral entry/infection of pseudotyped murine leukemia viruses expressing pathogenic NWA glycop

62 ammaretrovirus glycoproteins, such as Friend murine leukemia virus (F-MLV) Env, but not with the rela

63 ) in the envelope glycoprotein of the Friend murine leukemia virus (F-MLV) ISD has been reported to a

64 ith defined mixtures of the ecotropic Friend murine leukemia virus (F-MuLV) and different polytropic

65 Lymph-borne Friend murine leukemia virus (FrMLV) exploits the sentinel macr

66 The retrovirus Friend murine leukemia virus (FrMLV) infects a subtype of B cel

67 kely the functionally equivalent sequence in murine leukemia virus Gag has been inferred by mutationa

68 main inserted at random positions throughout murine leukemia virus Gag-Pol, then selecting for varian

69 ells are shown to restrict the expression of murine leukemia virus genomes but not retroviral genomes

70 ith the parental wild-type ecotropic Moloney murine leukemia virus glycoprotein through the ecotropic

71 on by retroviruses that are derived from the murine leukemia virus, human immunodeficiency virus type

72 magnetic resonance structure of the Moloney murine leukemia virus IN (M-MLV) C-terminal domain (CTD)

73 estricts N-tropic (N-MLV), but not B-tropic, murine leukemia virus in a manner dependent upon residue

74 hronically infected with the gammaretrovirus murine leukemia virus in which receptor has been downreg

75 wn of SSRP1 reduces HIV-1 infection, but not Murine Leukemia Virus, in human CD4(+) T cells.

76 crossover rate similar to that of HIV-1 and murine leukemia virus, indicating that the extremely hig

77 In murine leukemia virus-induced myeloid leukemia in mice,

78 mic lymphocytes by a mink cell focus-forming murine leukemia virus induces apoptosis during the prele

79 se, encoded by the v-Abl oncogene of Abelson murine leukemia virus induces transformation of progenit

80 We found a previously unknown murine leukemia virus infection in one cell line.

81 enhanced antiviral activity against N-tropic murine leukemia virus infection.

82 -5-positive (Lgr5(+)) and B lymphoma moloney murine leukemia virus insertion region homolog-1-positiv

83 The B-lymphoma Moloney murine leukemia virus insertion region-1 protein (BMI1)

84 is (Arabidopsis thaliana) B lymphoma Moloney murine leukemia virus insertion region1 homolog (BMI1) P

85 B-cell-specific Moloney murine leukemia virus integration site 1 (BMI1) is a com

86 e the role of Bmi-1 (B-cell-specific Moloney murine leukemia virus integration site 1) as a regulator

87 We generated murine leukemia virus integrations in human HepG2 and K5

88 Injection of the LP-BM5 murine leukemia virus into mice causes murine AIDS, a di

89 profile of raltegravir on the replication of murine leukemia virus is similar to that for HIV, and th

90 Replication of the murine leukemia viruses is strongly suppressed in mouse

91 ession of proviral insertion site of Moloney murine leukemia virus kinases (Pim-1, -2, and -3) in can

92 Moloney murine leukemia virus-like particles (M-VLPs) were compl

93 Non-infectious murine leukemia virus-like particles (M-VLPs) were elect

94 mal recessive mutation (Lamc2(jeb)) due to a murine leukemia virus long terminal repeat insertion in

95 LTR) was found to be higher than the Moloney murine leukemia virus LTRs in both LNCaP and WPMY-1 (sim

96 Moloney murine leukemia virus (M-MLV) replication is restricted

97 In the case of the ecotropic Moloney murine leukemia virus (M-MLV), the Nef-like effect is me

98 that gPr80gag facilitates release of Moloney murine leukemia virus (M-MuLV) from cells along an IFN-s

99 deficiency virus, type 1 (HIV-1) and Moloney murine leukemia virus (M-MuLV), we determined the effect

100 n immunodeficiency virus type 1) and Moloney murine leukemia virus (M-MuLV), we evaluated how individ

101 The Env protein of murine leukemia virus matures by two cleavage events.

102 ock the release of HIV-1, as well as that of murine leukemia virus (MLV) and Ebola virus (EBOV); knoc

103 We demonstrate that murine leukemia virus (MLV) and human immunodeficiency v

104 tion by mouse mammary tumor virus (MMTV) and murine leukemia virus (MLV) and that there are polymorph

105 the pol gene of gammaretroviruses, including murine leukemia virus (MLV) and xenotropic murine leukem

106 Using the murine leukemia virus (MLV) as a model retrovirus, we ha

107 The envelope protein (Env) from the CasBrE murine leukemia virus (MLV) can cause acute spongiform n

108 Murine leukemia virus (MLV) can efficiently spread in ti

109 IM proteins previously identified to inhibit murine leukemia virus (MLV) demonstrated an ability to i

110 gamma-Retroviral murine leukemia virus (MLV) DNA integration into the hos

111 tionship between two recent additions to the murine leukemia virus (MLV) ecotropic subgroup: Mus cerv

112 It is not known if murine leukemia virus (MLV) encodes a Vif-like protein.

113 The glycoprotein murine leukemia virus (MLV) Env can readily form pseudot

114 y, we found that the cytoplasmic tail of the murine leukemia virus (MLV) Env could functionally subst

115 The infectivity of HIV-1 pseudotyped with murine leukemia virus (MLV) Env was not affected by Vpu.

116 ty, we generated chimeric constructs between murine leukemia virus (MLV) Gag and HBV Core to determin

117 The p12 protein of murine leukemia virus (MLV) Gag is associated with the p

118 Here, we show that murine leukemia virus (MLV) has a unique means of counte

119 Murine leukemia virus (MLV) has been studied as one of t

120 and Sleeping Beauty (SB) transposons and the murine leukemia virus (MLV) in mouse embryonic stem cell

121 rved peptide sequence from the C terminus of murine leukemia virus (MLV) IN.

122 nificantly affects HIV-1 replication but not murine leukemia virus (MLV) infection and that miR-128 m

123 The roles of cellular proteases in Moloney murine leukemia virus (MLV) infection were investigated

124 We report alterations to the murine leukemia virus (MLV) integrase (IN) protein that

125 n 3 protein under conditions whereby Moloney murine leukemia virus (MLV) integrase failed to do so, s

126 of understanding the molecular mechanisms of murine leukemia virus (MLV) integration into host chroma

127 We found that the preintegration complex of murine leukemia virus (MLV) interacts with the dynein co

128 n A3G but is sensitive to murine A3, whereas murine leukemia virus (MLV) is relatively resistant to m

129 Murine leukemia virus (MLV) p12, encoded within Gag, bin

130 interferon-alpha-responsive manner, captures murine leukemia virus (MLV) particles and mediates their

131 form of this glycoprotein is compatible with murine leukemia virus (MLV) particles but incompatible w

132 the efficiencies of restriction of HIV-1 and murine leukemia virus (MLV) particles containing various

133 w analyzed the mRNA content of Psi- and Psi+ murine leukemia virus (MLV) particles using both microar

134 infectious anemia virus (EIAV), or N-tropic murine leukemia virus (MLV) postentry and supported late

135 rs to integrate within active genes, whereas murine leukemia virus (MLV) prefers to integrate near tr

136 l antisera, each prepared against a purified murine leukemia virus (MLV) protein.

137 binding site (PBS)-dependent restriction of murine leukemia virus (MLV) replication in embryonic ste

138 Moloney murine leukemia virus (MLV) selectively encapsidates hos

139 ted glycosylated Gag (glycoGag) protein of a murine leukemia virus (MLV) similarly enhance the infect

140 viruses, we engineered a fluorescent Moloney murine leukemia virus (MLV) system consisting of MLV-int

141 TR1.3 is a Friend murine leukemia virus (MLV) that induces selective syncy

142 Infection with murine leukemia virus (MLV) TR1.3 or the related molecul

143 nterrogated by measuring the cleavage of the murine leukemia virus (MLV) transmembrane Env protein by

144 Using a murine leukemia virus (MLV) variant with an unstable cap

145 ertionally mutagenized somatic cells using a murine leukemia virus (MLV) vector.

146 enhancement of the photonic inactivation of Murine Leukemia Virus (MLV) via 805 nm femtosecond pulse

147 ile infection by the gammaretrovirus Moloney murine leukemia virus (MLV) was unaffected.

148 the properties of the Gag protein of Moloney murine leukemia virus (MLV), a gammaretrovirus.

149 also by vectors bearing the envelope of 10A1 murine leukemia virus (MLV), a murine retrovirus that ca

150 For retroviruses such as HIV-1 and murine leukemia virus (MLV), active receptor recruitment

151 well as simian immunodeficiency virus (SIV), murine leukemia virus (MLV), and the retrotransposon Mus

152 ein for the generation of pseudotyped HIV-1, murine leukemia virus (MLV), and vesicular stomatitis vi

153 Gammaretroviruses, such as murine leukemia virus (MLV), are functionally distinguis

154 oviral vectors, including those derived from murine leukemia virus (MLV), bearing heterologous Env pr

155 and NC domains in gammaretroviruses, such as murine leukemia virus (MLV), is unique.

156 eported to be contaminated with an ecotropic murine leukemia virus (MLV), raising questions about the

157 four different retroviruses: HIV-1, Moloney murine leukemia virus (MLV), Rous sarcoma virus (RSV), a

158 For simple retroviruses, such as murine leukemia virus (MLV), the identities of the cellu

159 y the glycosylated Gag (glycoGag) protein of murine leukemia virus (MLV), the S2 protein of equine in

160 modifications present in a model retrovirus, murine leukemia virus (MLV), using mass spectrometry and

161 se, we used a shuttle vector system in which murine leukemia virus (MLV)-based proviral targets prese

162 ng primary human CD4(+) T lymphocytes with a murine leukemia virus (MLV)-based retroviral vector or x

163 ments in the long terminal repeats (LTRs) of murine leukemia virus (MLV)-based vectors and the vector

164 an gene therapy approaches utilize HIV-1- or murine leukemia virus (MLV)-based vectors, which prefere

165 t may be safer than that of standard Moloney murine leukemia virus (MLV)-derived retroviral vectors.

166 n immunodeficiency virus type 1 (HIV-1)- and murine leukemia virus (MLV)-derived viral vectors, respe

167 ing, are a newly appreciated viral target in murine leukemia virus (MLV)-induced neurodegeneration.

168 The association of xenotropic murine leukemia virus (MLV)-related virus (XMRV) in pros

169 four subsequent reports failed to detect any murine leukemia virus (MLV)-related virus gene sequences

170 virus-related virus (XMRV) as well as other murine leukemia virus (MLV)-related viruses, though not

171 pressed by most gammaretroviruses, including murine leukemia virus (MLV).

172 (mA3) and human APOBEC3G (hA3G) upon Moloney murine leukemia virus (MLV).

173 an immunodeficiency virus type 1 (HIV-1) and murine leukemia virus (MLV).

174 -Pfizer monkey virus (M-PMV) but not Moloney murine leukemia virus (MLV).

175 unable to support the replication of Moloney murine leukemia virus (MLV).

176 CD4(+) T lymphocytes are natural targets of murine leukemia virus (MLV).

177 Murine leukemia viruses (MLVs) and related retroelements

178 Certain murine leukemia viruses (MLVs) are capable of inducing f

179 Many murine leukemia viruses (MLVs) are partially resistant t

180 Mink cell focus-forming (MCF) murine leukemia viruses (MLVs) are the etiologic agent o

181 Certain murine leukemia viruses (MLVs) can induce progressive no

182 The generation of cytopathic effects by murine leukemia viruses (MLVs) in different cell types c

183 for repressing the expression of endogenous murine leukemia viruses (MLVs) in mouse liver.

184 Murine leukemia viruses (MLVs), including xenotropic-MLV

185 Members of the gammaretroviruses--such as murine leukemia viruses (MLVs), most notably XMRV [xenot

186 An RNA kissing loop from the Moloney murine leukemia virus (MMLV) exhibits unusual mechanical

187 ay a similar preintegrative role for Moloney murine leukemia virus (MMLV) in addition to HIV-1.

188 he 3' end processing site within the Moloney murine leukemia virus (MMLV) LTR d(TCTTTCATT), a host-gu

189 elity, we measured the error rate of Moloney murine leukemia virus (MMLV) RT in the presence of sever

190 n the template switching property of Moloney murine leukemia virus (MMLV)-type reverse transcriptases

191 markedly inhibits the replication of Moloney murine leukemia virus (Mo-MLV) and is required for the a

192 A crystallographic study of the Moloney murine leukemia virus (Mo-MLV) RNase H domain was perfor

193 A/DNMT3L complex to newly integrated Moloney murine leukemia virus (Mo-MuLV) proviral DNA.

194 eas the prototypical gammaretrovirus Moloney murine leukemia virus (MoMLV) favors strong enhancers an

195 Moloney murine leukemia virus (MoMLV) Gag utilizes its late (L)

196 oviral reverse transcriptase (RT) of Moloney murine leukemia virus (MoMLV) is expressed in the form o

197 o examine the role of this domain in Moloney murine leukemia virus (MoMLV) replication, we analyzed 1

198 The Moloney murine leukemia virus (MoMLV) ribonucleoprotein complex

199 ase, but not the RNase H function of Moloney Murine Leukemia Virus (MoMLV) RT and also inhibited Esch

200 h show that tetherin does not affect Moloney murine leukemia virus (MoMLV) spread, and only minimally

201 cle ultrastructure highly similar to Moloney murine leukemia virus (MoMLV), another gammaretrovirus.

202 The ts1 mutant of the Moloney murine leukemia virus (MoMuLV) causes neurodegeneration

203 studies with small fragments of the Moloney murine leukemia virus (MoMuLV) genome suggested that sel

204 The ts1 mutant of Moloney murine leukemia virus (MoMuLV) induces a neurodegenerati

205 enic temperature-sensitive mutant of Moloney murine leukemia virus (MoMuLV-ts1), results in motor neu

206 odies against clade C HIV-1 gp140, gp120, or murine leukemia virus (MuLV) gp70-scaffolded V1/V2 and t

207 The p12 protein of murine leukemia virus (MuLV) group-specific antigen (Gag

208 PVC-211 murine leukemia virus (MuLV) is a neuropathogenic retrov

209 MEL cells derived from Friend murine leukemia virus (MuLV) or ME26 MuLV-infected mice,

210 Moloney murine leukemia virus (MuLV) preferentially captures tRN

211 from scarce, femtomole quantities of Moloney murine leukemia virus (MuLV) RNA inside authentic virion

212 (2+) (~0.25 mM) and is comparable to Moloney murine leukemia virus (MuLV) RT fidelity.

213 We report here a murine leukemia virus (MuLV) that utilizes its glycosyla

214 High expression of murine leukemia virus (MuLV) transcripts was observed in

215 on with mouse mammary tumor virus (MMTV) and murine leukemia virus (MuLV) via an adaptive immune mech

216 besides MMTV, the animals were infected with murine leukemia virus (MuLV), a gammaretrovirus.

217 n the gammaretroviruses, typified by Moloney murine leukemia virus (MuLV), gag and pol are in the sam

218 opic virus 1 (Bxv1), a xenotropic endogenous murine leukemia virus (MuLV), is present in these 2 rece

219 onatal wild-type (WT) or Mll-AF9 mice with a murine leukemia virus (MuLV).

220 set was found to also contain reads from the murine leukemia virus (MuLV).

221 wever, the mechanism of APOBEC inhibition of murine leukemia viruses (MuLVs) does not appear to be G-

222 All gammaretroviruses, including murine leukemia viruses (MuLVs), feline leukemia viruses

223 viruses that generate recombinant polytropic murine leukemia viruses (MuLVs).

224 nfected with mixtures of mouse retroviruses (murine leukemia viruses [MuLVs]) exhibit dramatically al

225 For the restriction of N-tropic murine leukemia virus (N-MLV) and equine infectious anem

226 rs TRIM5alpha(hu) and Fv-1 restrict N-tropic murine leukemia virus (N-MLV) infection at an early post

227 capsid, we had previously selected N-tropic murine leukemia virus (N-MLV) mutants escaping from rhes

228 iction of the TRIM5alpha-sensitive, N-tropic murine leukemia virus (N-MLV) rendered HIV-1 transductio

229 with human TRIM5alpha inhibition of N-tropic murine leukemia virus (N-MLV).

230 The temperature-sensitive form of Abelson murine leukemia virus offers a reversible model to study

231 ells inhibits the replication of HIV but not murine leukemia virus or chikungunya virus.

232 The infectivity of HIV-1 virions bearing murine leukemia virus or vesicular stomatitis virus glyc

233 The provirus integration site for Moloney murine leukemia virus (Pim) 1 kinase is an oncogenic ser

234 genic (proviral integration site for Moloney murine leukemia virus (PIM) 1, 2, and 3 kinases in a NF-

235 Proviral integration site for Moloney murine leukemia virus (Pim) kinases are serine/threonine

236 ecific proviral integration site for Moloney murine leukemia virus (PIM) kinases PIM1 and PIM2 have b

237 f SCID temperature-sensitive form of Abelson murine leukemia virus pre-B cells.

238 cture of the double hairpin from the Moloney murine leukemia virus ([Psi(CD)](2), 132 nt, 42.8 kDa) u

239 neonatal infection of rats with the PVC-211 murine leukemia virus (PVC-211 MuLV) and its underlying

240 Homology requirements for Moloney murine leukemia virus recombination were addressed in th

241 We investigated the prevalence of xenotropic murine leukemia virus-related virus (XMRV) among 293 par

242 tly, CFS has been associated with xenotropic murine leukemia virus-related virus (XMRV) as well as ot

243 Xenotropic murine leukemia virus-related virus (XMRV) has been foun

244 Although xenotropic murine leukemia virus-related virus (XMRV) has been prev

245 The xenotropic murine leukemia virus-related virus (XMRV) has recently

246 The discovery of xenotropic murine leukemia virus-related virus (XMRV) in human tiss

247 tions regarding the prevalence of xenotropic murine leukemia virus-related virus (XMRV) in patients w

248 ecent study identified DNA from a xenotropic murine leukemia virus-related virus (XMRV) in peripheral

249 Xenotropic murine leukemia virus-related virus (XMRV) infection was

250 We analyzed xenotropic murine leukemia virus-related virus (XMRV) integration s

251 Xenotropic murine leukemia virus-related virus (XMRV) is a gammaret

252 Xenotropic murine leukemia virus-related virus (XMRV) is a gammaret

253 Xenotropic murine leukemia virus-related virus (XMRV) is a gammaret

254 Xenotropic murine leukemia virus-related virus (XMRV) is a gammaret

255 Xenotropic murine leukemia virus-related virus (XMRV) is a new huma

256 Xenotropic murine leukemia virus-related virus (XMRV) is a novel hu

257 Xenotropic murine leukemia virus-related virus (XMRV) was first ide

258 Xenotropic murine leukemia virus-related virus (XMRV) was previousl

259 Xenotropic murine leukemia virus-related virus (XMRV) was recently

260 iency virus type-1 (HIV-1) and of xenotropic murine leukemia virus-related virus (XMRV), a gammaretro

261 Xenotropic murine leukemia virus-related virus (XMRV), a gammaretro

262 (MLV)-based retroviral vector or xenotropic murine leukemia virus-related virus (XMRV), and isolated

263 A novel gammaretrovirus, xenotropic murine leukemia virus-related virus (XMRV), has been ide

264 DNA from a human gammaretrovirus, xenotropic murine leukemia virus-related virus (XMRV), in 68 of 101

265 described gammaretrovirus genome, xenotropic murine leukemia virus-related virus (XMRV), in prostate

266 e newly identified retrovirus-the xenotropic murine leukemia virus-related virus (XMRV)-has recently

267 s of authentic genomic RNA of the xenotropic murine leukemia virus-related virus (XMRV).

268 d with the human retrovirus XMRV (xenotropic murine leukemia virus-related virus) can induce rare foc

269 The retrovirus XMRV (xenotropic murine leukemia virus-related virus) has been detected i

270 a gammaretrovirus, termed "XMRV" (xenotropic murine leukemia virus-related virus) in prostate cancers

271 The human retrovirus XMRV (xenotropic murine leukemia virus-related virus) is associated with

272 The human retrovirus XMRV (xenotropic murine leukemia virus-related virus) is associated with

273 ow that a retrovirus called XMRV (xenotropic murine leukemia virus-related virus) was present in the

274 ated the need for Vpu in enhancing HIV-1 and murine leukemia virus release.

275 inding to Fc; the same hot-spots control HIV/murine leukemia virus restriction by TRIM5alpha and medi

276 eonatal infection of these mice with Moloney murine leukemia virus resulted in accelerated tumor onse

277 tor resistance of several commercial Moloney murine leukemia virus reverse transcriptase (MMLV RT) en

278 t to increase the thermostability of Moloney Murine Leukemia Virus reverse transcriptase (MMLV RT), w

279 ted human TRIM5alpha restriction of N-tropic murine leukemia virus reverse transcription.

280 We probed the structure of murine leukemia virus RNA inside virus particles using S

281 ied unexpectedly high levels of m(5)C in the murine leukemia virus RNA, precisely mapped its location

282 These compounds also inhibit Moloney murine leukemia virus RT but not the Klenow fragment of

283 Tan-1 RT enzymatically mimics oncoretroviral murine leukemia virus RT which is characterized by its l

284 Avian myeloblastosis and Moloney murine leukemia virus RTs also bound more stably to RNA-

285 l replication in vivo, I constructed a novel murine leukemia virus strain (FMLV-IL-1beta) that encode

286 , feline leukemia virus subgroup T, and 10A1 murine leukemia virus, this receptor is the human type I

287 1 with a replaced envelope gene from Moloney murine leukemia virus to allow HTLV-1 to fuse with murin

288 Using Abelson murine leukemia virus-transformed B cells to model this

289 iption during clonal expansion using Abelson murine leukemia virus-transformed B cells.

290 neurovirulent viruses FrCas(NC) and Moloney murine leukemia virus ts1 indicate that the nascent enve

291 be increased by 3- to 5-fold by placing the murine leukemia virus UAG read-through element upstream

292 icrobe, Stavrou et al. (2015) reveal how the murine leukemia virus uses a sugar-protein shield to pro

293 Replicating Moloney murine leukemia virus viral production was greater in XP

294 TM cleavage in Moloney murine leukemia virus was inhibited by amprenavir, and t

295 ffect was specific to HIV in that release of murine leukemia virus was minimally affected by the pres

296 stingly, our fusion protein did not restrict murine leukemia virus, which does not incorporate Vpr.

297 r, mouse APOBEC3 protein blocks infection by murine leukemia viruses without catalyzing this base cha

298 variant nonpermissive to XMRV and xenotropic murine leukemia virus (X-MLV) infection, suggesting that

299 iruses (MLVs), most notably XMRV [xenotropic murine leukemia virus (X-MLV)-related virus--have been r

300 g murine leukemia virus (MLV) and xenotropic murine leukemia virus (XMRV), named the CAE (cytoplasmic